45.3 Nephrolithiasis & Acute Urinary Tract Obstruction

Epidemiology, Pathophysiology & Stone Compositions

Nephrolithiasis (urolithiasis) affects approximately 10% to 12% of men and 7% to 8% of women in the United States during their lifetime, with annual healthcare costs exceeding $5 billion. Following an initial stone episode, the 5-year recurrence rate approaches 50% in the absence of targeted metabolic evaluation and dietary modification.

Physicochemical Pathogenesis

Stone formation is driven by urinary supersaturation of insoluble mineral salts, exceeding the thermodynamic solubility product ($K_{sp}$). This triggers crystal nucleation, crystal growth, and crystal aggregation.

1. Randall's Plaques: In the majority of calcium oxalate stone formers, stone formation originates as subepithelial deposits of calcium phosphate in the basement membrane of the thin loops of Henle. These deposits erode through the papillary urothelium into the renal calyx, serving as an exposed, mineralized nidus (Randall's plaque) upon which calcium oxalate rapidly precipitates.
2. Promoters vs. Inhibitors: Pathophysiologic stone risk represents an imbalance between urinary stone promoters (calcium, oxalate, uric acid) and endogenous inhibitors of crystallization (most notably urinary citrate, pyrophosphate, and magnesium).

                  COMPREHENSIVE COMPARISON OF RENAL CALCULI

   Stone Type        Prevalence  Radiopacity  Urine pH    Crystal Shape        Key Risk Factors & Etiologies
   ═══════════════════════════════════════════════════════════════════════════════════════════════════════════
   Calcium Oxalate   70% to 80%  Radiopaque   Variable    Bipyramidal          • Idiopathic hypercalciuria
                                 (Dense)      (5.5 - 6.5) "Envelope" /         • Enteric hyperoxaluria (Crohn,
                                                          dumbbell               bariatric surgery, malabsorption)
                                                                               • Hypocitraturia (acidosis, diarrhea)

   Calcium Phosphate 10% to 15%  Radiopaque   Alkaline    Wedge-shaped prisms  • Distal Renal Tubular Acidosis (RTA 1)
                                 (Very dense) (>7.0)      or rosettes          • Primary hyperparathyroidism

   Uric Acid         5% to 10%   RADIOLUCENT  Acidic      Pleomorphic          • Persistent acidic urine (pH <5.5)
                                 on X-ray;    (<5.5)      rhomboids or         • Gout, metabolic syndrome, diabetes
                                 Visible CT               needles              • Chronic diarrhea (bicarbonate loss)

   Struvite          5% to 10%   Radiopaque   Alkaline    Rectangular          • Urease-producing bacteria
   (Mg-NH4-PO4;                  (Variable)   (>7.2)      "Coffin-lid"           (Proteus mirabilis, Klebsiella)
   "Staghorn")                                            prisms               • Massive staghorn calculi

   Cystine           1%          Faintly      Acidic      Pathognomonic        • Autosomal recessive cystinuria
                                 Radiopaque   (<6.5)      HEXAGONAL            • Defective COLA transporter
                                 (Ground-glass)           plates               • Sodium cyanide-nitroprusside (+)
   ═══════════════════════════════════════════════════════════════════════════════════════════════════════════

Detailed Stone Chemistry & Metabolic Drivers

1. Calcium Oxalate Calculi (70% to 80%)

• Idiopathic Hypercalciuria: The most prevalent identifiable metabolic abnormality, present in >50% of calcium stone formers (defined as 24-hour urinary calcium >250 mg in women or >300 mg in men, or >4 mg/kg/day). Driven by increased intestinal calcium absorption, reduced renal tubular calcium reabsorption, or bone resorptive states.
• Hyperoxaluria: Oxalate is an organic dicarboxylic acid derived from endogenous hepatic metabolism and dietary absorption (spinach, rhubarb, beets, nuts, chocolate, black tea).
  • Enteric Hyperoxaluria: Seen in Crohn disease, chronic pancreatitis, celiac sprue, and Roux-en-Y gastric bypass. In malabsorptive states, unabsorbed fatty acids bind luminal calcium to form insoluble soaps. This leaves dietary oxalate unbound, free, and hyper-absorbed in the colon, precipitating severe calcium oxalate stones.
• Hypocitraturia: Urinary citrate is the primary endogenous defense against calcium nephrolithiasis. Citrate binds ionized calcium in the tubular lumen, forming a soluble calcium-citrate complex that lowers free calcium ion activity and prevents crystal aggregation. Hypocitraturia (<320 mg/day) is triggered by chronic intracellular metabolic acidosis (distal RTA, chronic diarrhea, excessive animal protein intake, hypokalemia, or carbonic anhydrase inhibitors like topiramate).
• The Dietary Calcium Paradox: Patients mistakenly believe that restricting dietary calcium prevents calcium stones. In reality, low dietary calcium INCREASES stone recurrence. In the gut lumen, adequate dietary calcium binds dietary oxalate, forming insoluble calcium oxalate that is excreted in feces. If dietary calcium is restricted, free oxalate absorption skyrockets, driving hyperoxaluria. Patients must maintain normal dietary calcium intake (1,000 to 1,200 mg/day) taken with meals, while restricting dietary sodium (<2,000 mg/day; sodium excretion drives passive calcium excretion in the proximal tubule) and limiting excess animal protein.

2. Calcium Phosphate Calculi (10% to 15%)

• Calcium phosphate precipitates exclusively in alkaline urine (pH >7.0).
• Strongly associated with two major conditions:
  1. Distal Renal Tubular Acidosis (Type 1 RTA): Impaired collecting duct hydrogen ion excretion produces a persistently elevated urine pH (>5.5 to 6.5) alongside systemic hypokalemic metabolic acidosis and hypocitraturia, creating the ideal milieu for nephrocalcinosis and brushite/apatite stones.
  2. Primary Hyperparathyroidism: Excessive parathyroid hormone (PTH) drives hypercalcemia, hypercalciuria, and alkaline urine.

3. Uric Acid Calculi (5% to 10%)

• The Critical Role of Urine pH: The pKa of uric acid is 5.35. At a urine pH <5.5, over 85% of uric acid exists in its un-ionized, highly insoluble form (solubility <100 mg/L). At a urine pH >6.5, uric acid dissociates into soluble urate salts (solubility >1,000 mg/L—a 10-fold increase!).
• Etiology: Driven primarily by persistently low urine pH (<5.5), commonly seen in metabolic syndrome and type 2 diabetes mellitus (impaired renal tubular ammoniagenesis), chronic diarrhea (gastrointestinal loss of bicarbonate leading to concentrated, acidic urine), and gout or myeloproliferative disorders.
• Radiographic Feature: Uric acid stones have a density similar to soft tissue; they are COMPLETELY RADIOLUCENT on plain X-rays (KUB), but appear clearly on non-contrast CT (Hounsfield units typically 300 to 500 HU).
• Chemolysis (Medical Dissolution): Uric acid stones are uniquely treatable and dissolvable without surgical intervention through urinary alkalinization. Oral potassium citrate (20 to 30 mEq two to three times daily) is titrated to maintain a urinary pH of 6.5 to 7.0. Over-alkalinization (pH >7.5) must be avoided to prevent calcium phosphate precipitation on the stone surface. Allopurinol is added only if hyperuricemia or marked hyperuricosuria is present.

4. Struvite / Triple Phosphate Calculi (5% to 10%)

• Pathogenesis: Composed of magnesium ammonium phosphate ($MgNH_4PO_4 \cdot 6H_2O$) and carbonate apatite. They form exclusively in the presence of upper urinary tract infections with urea-splitting (urease-producing) bacteria:
  • Proteus mirabilis (most common)
  • Klebsiella pneumoniae, Pseudomonas aeruginosa, Providencia, Morganella
  • Note: Escherichia coli DOES NOT produce urease and cannot cause struvite calculi!
• Biochemical Reaction: Bacterial urease hydrolyzes urea into ammonia and carbon dioxide: $\text{Urea} + H_2O \xrightarrow{\text{Urease}} 2NH_3 + CO_2$ Ammonia buffers hydrogen ions to form ammonium ($NH_4^+$) and hydroxide ($OH^-$), driving urine pH to highly alkaline levels (>7.2 to 8.0), which precipitates magnesium, ammonium, and phosphate.
• Staghorn Calculi: Struvite stones rapidly enlarge to fill the renal pelvis and calyces, creating a branched "staghorn" calculus. They frequently grow insidiously without classic renal colic, presenting with recurrent UTIs, alkaline urine, persistent pyuria, or progressive renal failure.
• Management: Struvite calculi CANNOT be sterilized with antibiotics alone because bacteria reside within the crystalline matrix. Definitive therapy requires complete surgical removal (typically Percutaneous Nephrolithotomy [PCNL]), followed by targeted antimicrobial therapy.

5. Cystine Calculi (1%)

• Etiology: Autosomal recessive genetic mutation in SLC3A1 or SLC7A9, impairing the dibasic amino acid transporter in the proximal tubule. This causes massive urinary excretion of Cystine, Ornithine, Lysine, and Arginine (COLA).
• Diagnosis: Pathognomonic flat, hexagonal crystals on urinalysis; positive sodium cyanide-nitroprusside screening test (turns red-purple).
• Management: Aggressive hydration (>3.5 to 4 L/day to maintain urine output >3 L/day, including waking at night to drink), urinary alkalinization with potassium citrate (target pH >7.0 to 7.5), and thiol-chelating agents (tiopronin or D-penicillamine) for refractory stone formation.

---

Clinical Presentation of Acute Renal Colic

Acute renal colic is universally described by patients as one of the most agonizing, excruciating pain experiences in medicine.

Cardinal Clinical Manifestations

• Sudden Onset of Severe Flank Pain: Abrupt, unrelenting pain localized to the costovertebral angle, waxing and waning in paroxysms as the ureter hyperperistalses against obstruction.
• Classic Dermatomal Radiation: Pain radiates anteriorly and inferiorly along the anatomical course of the ureter into the ipsilateral lower abdominal quadrant, groin, scrotum/testicle in males, or labium majorum in females (T10-L1 dermatomes).
• Motor Restlessness (The "Colic Writhing"): The pain is visceral. In stark contrast to patients with acute peritonitis (who lie rigidly motionless because movement exacerbates somatic peritoneal irritation), patients with acute renal colic are characteristically unable to find a comfortable position, pacing the examination room, writhing, or tossing and turning on the gurney.
• Autonomic Signs: Severe nausea, projectile vomiting, diaphoresis, pallor, and reflex hypertension/tachycardia.
• Irritative Bladder Symptoms (UVJ Impaction): When a calculus is lodged at the ureterovesical junction (UVJ—the narrowest anatomical constriction), it causes intense trigonal irritation, producing severe urinary frequency, urgency, dysuria, and pelvic fullness that mimics lower urinary tract cystitis.

Urinalysis in Renal Colic

• Microscopic or Gross Hematuria: Present in 85% to 90% of acute nephrolithiasis presentations.
• CRITICAL EXAM PEARL: The absence of hematuria occurs in 10% to 15% of confirmed stone cases! Complete, high-grade ureteral obstruction prevents blood from flowing past the calculus into the bladder, resulting in a normal urinalysis. The absence of hematuria does NOT rule out acute nephrolithiasis in a patient with classic flank colic.

---

Diagnostic Imaging Protocols: NCCT vs. Renal Ultrasound

                  DIAGNOSTIC IMAGING MODALITIES IN NEPHROLITHIASIS

   Imaging Modality    Diagnostic Performance      Role, Indications & Clinical Pearls
   ═══════════════════════════════════════════════════════════════════════════════════════════
   Low-Dose            • Sensitivity: 98%          • DIAGNOSTIC GOLD STANDARD in non-pregnant adults
   Non-Contrast CT     • Specificity: 97%          • Accurately measures stone size (maximum axial
   Abdomen/Pelvis      • Radiation: ~1.5 - 3 mSv     dimension), exact location, and Hounsfield units
   (NCCT)                                          • Detects secondary obstruction: hydronephrosis,
                                                     hydroureter, and perinephric fat stranding

   Renal & Bladder     • Sensitivity: 70% to 85%   • FIRST-LINE IMAGING in PREGNANCY & PEDIATRICS
   Ultrasound          • Specificity: 90% to 95%   • Visualizes hydronephrosis (pelvicalyceal dilation)
                       • NO radiation exposure     • Identifies acoustic shadowing of renal stones
                                                   • Assesses ureteral jets on Doppler (absence = obstruction)
                                                   • Poor sensitivity for mid-ureteral stones and <5 mm stones

   Plain Radiographs   • Sensitivity: 50% to 60%   • Useful only for following known radiopaque
   (KUB: Kidneys,      • Specificity: 70%            calcium stones previously visible on X-ray
   Ureters, Bladder)   • Low cost & radiation      • Misses radiolucent uric acid stones entirely
   ═══════════════════════════════════════════════════════════════════════════════════════════

---

Urological Surgical Emergencies: Immediate Decompression Criteria

Primary care clinicians must immediately identify presentations that represent life-threatening urological crises requiring emergent decompression rather than conservative management.

              EMERGENT INDICATIONS FOR IMMEDIATE SURGICAL DECOMPRESSION

   1. OBSTRUCTING CALCULUS WITH CONCURRENT URINARY TRACT INFECTION / SEPSIS
      • Clinical Triad: Ureteral stone obstruction + Fever / Pyuria / Bacteremia + Sepsis
      • Pathophysiology: An obstructed renal collecting system under pressure creates an enclosed
        abscess, rapidly precipitating bacterial endotoxemia, septic shock, and renal destruction.
      • ACTION: IMMEDIATE EMERGENT SURGICAL DECOMPRESSION via:
        a) Retrograde Ureteral Stenting (Double-J stent), OR
        b) Percutaneous Nephrostomy (PCN) tube placement
      • Concurrent IV broad-spectrum antibiotics and fluid resuscitation.
      • CONTRAINDICATION: DO NOT attempt definitive stone fragmentation (lithotripsy) during sepsis!

   2. COMPLETE ANURIC OBSTRUCTION
      • Bilateral ureteral obstruction, OR acute obstruction of a solitary or transplanted kidney.
      • Rapidly induces anuric post-renal acute kidney injury, fatal hyperkalemia, and uremic coma.

   3. INTRACTABLE PAIN OR EMESIS
      • Severe, debilitating pain or persistent nausea/vomiting refractory to maximal IV analgesia.

   4. PROGRESSIVE RENAL INSUFFICIENCY
      • Persistent obstruction leading to progressive elevation in serum creatinine.

---

Conservative Medical Expulsive Therapy (MET) & Interventional Strategies

For uncomplicated ureteral calculi in hemodynamically stable patients without infection or severe renal compromise, management is dictated primarily by stone size and anatomical location.

                    MANAGEMENT BY CALCULUS SIZE & PASSAGE PROBABILITY

   Stone Size          Spontaneous Passage Rate    Recommended Clinical Management Strategy
   ═══════════════════════════════════════════════════════════════════════════════════════════
   < 5 mm              80% to 90% within 4 weeks   • Conservative outpatient trial of passage
                                                   • Oral hydration (2 to 3 L/day) + oral NSAIDs
                                                   • Urine straining with fine mesh filter
                                                   • Follow-up imaging in 2 to 4 weeks

   5 mm to 10 mm       ~50% within 4 to 6 weeks    • MEDICAL EXPULSIVE THERAPY (MET):
                                                     Tamsulosin 0.4 mg PO daily x 4 weeks
                                                   • Accelerates expulsion; reduces analgesic needs
                                                   • Elective intervention if not passed in 4-6 wk

   > 10 mm             <10% to 20%                 • Unlikely to pass spontaneously
                                                   • Conservative trials NOT recommended
                                                   • Early elective urologic intervention (SWL or URS)
   ═══════════════════════════════════════════════════════════════════════════════════════════

Medical Expulsive Therapy (MET) Protocol

• Alpha-1 Receptor Antagonists (Tamsulosin 0.4 mg PO daily): Alpha-1D and alpha-1A adrenergic receptors are densely distributed in the distal third of the human ureter. Tamsulosin inhibits basal ureteral smooth muscle tone and hyperperistaltic spasm while preserving antegrade propulsive flow. Clinical trials and meta-analyses demonstrate that tamsulosin:
  • Increases spontaneous expulsion rates by 20% to 30% for distal ureteral stones between 5 mm and 10 mm.
  • Reduces time to expulsion by 2 to 6 days.
  • Significantly decreases analgesic requirements and recurrent emergency department visits.
• Analgesia: Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) (e.g., Ketorolac 15-30 mg IV in the acute setting, followed by oral Ibuprofen 600-800 mg TID or Naproxen 500 mg BID) represent the first-line analgesics of choice for acute renal colic. NSAIDs inhibit cyclooxygenase, suppressing renal prostaglandin synthesis. This diminishes renal blood flow, lowers glomerular filtration rate, reduces renal pelvic pressure, and directly relieves ureteral smooth muscle spasm. Multiple clinical trials demonstrate that NSAIDs provide faster, more sustained pain relief with fewer adverse effects (sedation, vomiting) compared to opioids.
• Urine Straining & Metabolic Follow-Up: The patient must strain all urine through a fine mesh filter. Any recovered calculus must be sent for X-ray diffraction or infrared spectroscopy stone composition analysis. Follow-up imaging (ultrasound or low-dose KUB/CT) must be performed in 2 to 4 weeks to confirm passage and rule out "silent" asymptomatic obstruction, which can permanently destroy renal function without pain.

Definitive Urological Interventions

When stones fail conservative therapy, exceed 10 mm, or cause persistent obstruction:

1. Extracorporeal Shock Wave Lithotripsy (SWL): External acoustic shock waves focused under fluoroscopy or ultrasound to fragment stones into small gravel. Best suited for proximal ureteral or renal pelvis stones <20 mm (<2 cm). Contraindicated in pregnancy, untreated UTI, bleeding diathesis/anticoagulation, and hard stones (cystine, brushite).
2. Ureteroscopy (URS) with Laser Lithotripsy: Rigid or flexible ureteroscope advanced transurethrally into the ureter or renal pelvis, utilizing a Holmium:YAG or Thulium laser fiber to pulverize the calculus, followed by stone basket retrieval. The treatment of choice for distal ureteral stones, stones >10 mm, lower pole renal stones, and patients on anticoagulation or pregnant.
3. Percutaneous Nephrolithotomy (PCNL): Direct needle puncture into the renal calyx with tract dilation to accommodate a large-bore rigid nephroscope, allowing ultrasonic, pneumatic, or laser fragmentation. The gold standard for large renal calculi (>20 mm / >2 cm) and complex staghorn calculi.